C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/506 (2006.01) A61K 31/519 (2006.01) A61P 3/10 (2006.01) A61P 25/18 (2006.01) A61P 35/00 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 407/14 (2006.01) C07D 409/14 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01) C07D 473/16 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01) C07D 493/04 (2006.01) C07D 495/04 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01) C07D 521/00 (2006.01)
Patent
CA 2422299
This invention describes novel triazole compounds of formula (IX): wherein Z1~ is nitrogen or CR9~ and Z2~ is nitrogen or CH, provided that at least one of Z1~ and Z2~ is nitrogen; G is Ring C or Ring D; Ring C is selected from a phenyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, or 1,2,4-triazinyl ring, wherein said Ring C has one or two ortho substituents independently selected from -R1~; Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; Rx~ and Ry~ are independently selected from T-R3~, or Rx~ and Ry~ are taken together with their intervening atoms to form a fused ring; R1~, R3~, and T are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of GSK-3 and Aurora, for treating diseases such as diabetes, cancer, and Alzheimer's disease.
L'invention porte sur de nouveaux compos~s de triazole de formule (IX): dans laquelle: Z?1´ est azote ou CR?9´ et Z?2´ est azote ou CH, sous r~serve que l'un de Z?1´ et Z?2´ soit azote; G est cycle C or cycle D; cycle C est choisi parmi ph~nyle, pyridinyle, pyrimidinyle, pyridazinyle, pyrazinyle, ou cycle1,2,4-triazinyle, ledit cycle C ayant un ou deux substituants ortho choisis ind~pendamment parmi -R?1´; cycle D est un cycle monocyclique ~ 5-7 ~l~ments ou un cycle bicyclique ~ 8-10 ~l~ments 8-10, choisi parmi aryle, h~t~roaryle, h~t~rocyclyle ou carbocyclyle; R?x´ et R?y´ sont choisis ind~pendamment parmi T-R?3´, ou R?x´ et R?y´ pris ensemble avec leurs atomes intervenant forment un cycle fusionn~; R?1´, R?3´, et T sont d~crits dans la sp~cification. Lesdits compos~s sont des inhibiteurs de la prot~ine kinase et sp~cialement des inhibiteurs de la GSK-3 et de l'Aurora, pouvant traiter des maladies telles que la diabte, le cancer ou la maladie d'Alzheimer.
Bebbington David
Binch Haley
Charrier Jean-Damien
Golec Julian M.c.
Knegtel Ronald
Smart & Biggar
Vertex Pharmaceuticals Incorporated
LandOfFree
Triazole compounds useful as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole compounds useful as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole compounds useful as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1853683